Trial intelligence / Profile preview

Paracetamol and Ketorolac on RANK-L in Orthodontic Treatment

NCT05383820Phase 4Unknown

Sponsor
Universidad de Guadalajara
Start
Sep 2021
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ketorolac in acute pain (3 arms), sponsored by Universidad de Guadalajara. Primary endpoint: RANK-L at 5 days. Status: unknown.

02

Drugs

ketorolac
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT05383820.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05383820.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call